SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             _____________________

                                   FORM 8-K
                             _____________________


             CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                          COMMISSION FILE NO.: 0-24185


                          Date of Report: June 23, 2006


                         CENTRAL AMERICAN EQUITIES CORP.
            ------------------------------------------------------
            (Exact name of registrant as specified in its charter)


           Florida                                    65-0636168
     ---------------------------------------------------------------
    (State of other jurisdiction of                 (IRS Employer
     incorporation or organization)                  Identification No.)


      100 Wall Street, 15th Floor, New York, NY             10005
     ---------------------------------------------------------------
     (Address of principal executive offices)            (Zip Code)


                             212-232-0120 ext. 221
               --------------------------------------------------
               (Registrant's telephone number including area code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)
[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)
[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))
[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))



ITEM 5.03  CHANGE IN FISCAL YEAR

     On June 23, 2006 the Registrant's Board of Directors approved a change
in the Registrant's fiscal year.  The new fiscal year will end on June 30.

     Recently the Registrant was party to a merger agreement with Ostar
Pharmaceutical, Inc. ("Ostar").  Because the Registrant issued shares equal
to over 98% of its outstanding capital stock in connection with the merger
of Ostar into a subsidiary of the Registrant, Ostar is now considered the
reporting entity for accounting purposes.  For that reason, the Registrant
has changed its fiscal year to conform to the fiscal year of Ostar.

     The Registrant will not file a report for a transition period as a
result of the change in the Registrant's fiscal year, since there has been
no change in the periods of the Registrant's financial statements.

                                SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                 CENTRAL AMERICAN EQUITIES CORP.

                                 By: /s/ Zhenjiang Yue
                                 --------------------------------------
                                 Zhenjiang Yue, Chief Executive Officer